4.9 (735) · € 8.00 · En stock
IJMS, Free Full-Text
Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy
Role of the gut microbiota in anticancer therapy: from molecular mechanisms to clinical applications
Frontiers The impact of microbiome dysbiosis on T cell function within the tumor microenvironment (TME)
Role of gut microbiome in cancer immunotherapy: from predictive biomarker to therapeutic target, Experimental Hematology & Oncology
CD19 CAR-T cell therapy for Relapsed or Refractory Diffuse Large B Cell Lymphoma; Why does it Fail? - ScienceDirect
Infections after chimeric antigen receptor (CAR)‐T‐cell therapy for hematologic malignancies - Kampouri - 2023 - Transplant Infectious Disease - Wiley Online Library
Frontiers Predictive short/long-term efficacy biomarkers and resistance mechanisms of CD19-directed CAR-T immunotherapy in relapsed/refractory B- cell lymphomas
The heightened importance of the microbiome in cancer immunotherapy: Trends in Immunology
IJMS, Free Full-Text
Potential links between the microbiota and T cell immunity determine the tumor cell fate
Infections after chimeric antigen receptor (CAR)‐T‐cell therapy for hematologic malignancies - Kampouri - 2023 - Transplant Infectious Disease - Wiley Online Library
Synthetic Biology in Chimeric Antigen Receptor T (CAR T) Cell Engineering
Gut microbiome and CAR-T therapy, Experimental Hematology & Oncology